Search results: Sage Journals

Restricted accessArticle commentaryFirst published July, 2021

The cost-effectiveness of atezolizumab in first-line for metastatic triple negative breast cancer is heavily linked to PD-L1 level

Jacopo Giuliani, Beatrice Mantoan, Andrea Bonetti

Journal of Oncology Pharmacy Practice

Open accessReview articleFirst published June, 2026

A methodological review of pragmatic designs in acute stroke trials

Ayooluwanimi P Okikiolu, Sucharita Ray, Kamalesh Chakravarty [...]

International Journal of Stroke

Open accessReview articleFirst published 2019

Biological therapies and their clinical impact in the treatment of systemic lupus erythematosus

Rosalie Magro

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2019

Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials

Jeong Uk Lim, Seung Wook Hong, Jae-Hoon Ko

Therapeutic Advances in Respiratory Disease

Free accessReview articleFirst published August, 2015

Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma

Bart Hilvering, Luzheng Xue, Ian D. Pavord

Therapeutic Advances in Respiratory Disease

Restricted accessResearch articleFirst published July, 2009

The Influence of Enrollment Criteria on Recruitment and Outcome Distribution in Traumatic Brain Injury Studies: Results from the Impact Study

Bob Roozenbeek, Andrew I.R. Maas, Anthony Marmarou [...]

Journal of Neurotrauma

Restricted accessArticle commentaryFirst published September, 2020

The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal receptor-2 negative (HER-2) advanced or metastatic breast cancer

Jacopo Giuliani, Andrea Bonetti

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2023

Improving the lives of ethnically diverse family carers and people living with dementia using digital media resources – Protocol for the Draw-Care randomised controlled trial

Antonia Thodis, Thu-Ha Dang, Josefine Antoniades [...]

DIGITAL HEALTH

Open accessResearch articleFirst published January, 2018

Quality of Reporting in Oncology Randomized Controlled Trials

Huiyun Zhu, Si Chen, Pei Xie [...]

Cancer Control

Free accessOtherFirst published September, 2003

Methods for a Multisite Randomized Trial to Investigate the Effect of Constraint-Induced Movement Therapy in Improving Upper Extremity Function among Adults Recovering from a Cerebrovascular Stroke

Carolee J. Winstein, J. Philip Miller, Sarah Blanton [...]

Neurorehabilitation and Neural Repair

Restricted accessArticle commentaryFirst published July, 2021

The cost-effectiveness of atezolizumab in first-line for metastatic triple negative breast cancer is heavily linked to PD-L1 level

Jacopo Giuliani, Beatrice Mantoan, Andrea Bonetti

Journal of Oncology Pharmacy Practice

Open accessReview articleFirst published June, 2026

A methodological review of pragmatic designs in acute stroke trials

Ayooluwanimi P Okikiolu, Sucharita Ray, Kamalesh Chakravarty [...]

International Journal of Stroke

Open accessReview articleFirst published 2019

Biological therapies and their clinical impact in the treatment of systemic lupus erythematosus

Rosalie Magro

Therapeutic Advances in Musculoskeletal Disease

Open accessResearch articleFirst published 2019

Efficacy of inhaled ciprofloxacin agents for the treatment of bronchiectasis: a systematic review and meta-analysis of randomized controlled trials

Jeong Uk Lim, Seung Wook Hong, Jae-Hoon Ko

Therapeutic Advances in Respiratory Disease

Free accessReview articleFirst published August, 2015

Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma

Bart Hilvering, Luzheng Xue, Ian D. Pavord

Therapeutic Advances in Respiratory Disease

Restricted accessResearch articleFirst published July, 2009

The Influence of Enrollment Criteria on Recruitment and Outcome Distribution in Traumatic Brain Injury Studies: Results from the Impact Study

Bob Roozenbeek, Andrew I.R. Maas, Anthony Marmarou [...]

Journal of Neurotrauma

Restricted accessArticle commentaryFirst published September, 2020

The introduction of a third CDK4/6 inhibitor does not change the cost-effectiveness profile in first and subsequent-lines after progression or relapse during previous endocrine therapy in patients with hormone receptor positive (HR+)/human epidermal receptor-2 negative (HER-2) advanced or metastatic breast cancer

Jacopo Giuliani, Andrea Bonetti

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2023

Improving the lives of ethnically diverse family carers and people living with dementia using digital media resources – Protocol for the Draw-Care randomised controlled trial

Antonia Thodis, Thu-Ha Dang, Josefine Antoniades [...]

DIGITAL HEALTH

Open accessResearch articleFirst published January, 2018

Quality of Reporting in Oncology Randomized Controlled Trials

Huiyun Zhu, Si Chen, Pei Xie [...]

Cancer Control

Free accessOtherFirst published September, 2003

Methods for a Multisite Randomized Trial to Investigate the Effect of Constraint-Induced Movement Therapy in Improving Upper Extremity Function among Adults Recovering from a Cerebrovascular Stroke

Carolee J. Winstein, J. Philip Miller, Sarah Blanton [...]

Neurorehabilitation and Neural Repair